|
|
Antisense Therapeu (ASX:ANP) |
Marketwire
Sep 7
Comment
MELBOURNE, AUSTRALIA -- (Marketwire) -- 09/07/10 -- Antisense Therapeutics Ltd. (ASX: ANP) today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at The Palace Hotel in New York City on September 13,
Marketwire
Oct 13
Comment
MELBOURNE, AUSTRALIA -- (Marketwire) -- 10/13/09 -- Antisense Therapeutics Limited (PINKSHEETS: ATHJY) (ASX: ANP) -- ATL1103: Antisense drug that targets the growth hormone receptor is set to become ANP's next drug to move into clinical development
Marketwire
Aug 31
Comment
MELBOURNE, AUSTRALIA -- (Marketwire) -- 08/31/09 -- Antisense Therapeutics Limited (PINKSHEETS: ATHJY) (ASX: ANP) today announced that the Company is scheduled to present at the Rodman & Renshaw 11th Annual Global Healthcare Conference, on September
Marketwire
Jun 18
Comment
MELBOURNE, AUSTRALIA -- (Marketwire) -- 06/18/09 -- Antisense Therapeutics Ltd. (ASX: ANP) is pleased to report further positive results from its collaborative preclinical research studies on the therapeutic potential of ATL1101 in prostate cancer.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
